Institutional 13F Filings

Quarterly position changes from hedge funds and institutional investors.

Get trade alerts by text

We text you when insiders, Congress or big funds make new trades. Free.

Cardinal Capital Sells Out of T-Mobile US, Inc. (TMUS)

Cardinal Capital Management has completely exited its position in T-Mobile US, Inc.

$TMUS

Cardinal Capital Management Takes New Position in Granite REIT

Cardinal Capital Management has acquired a new stake in Granite Real Estate Investment Trust, reflecting growing interest in the REIT sector.

$GRTUF

Cardinal Capital Management Sells Out of LVMH Moët Hennessy

Cardinal Capital Management has completely exited its investment in LVMH Moët Hennessy, according to a recent filing.

$LVMUY

Cardinal Capital Reduces Stake in Manulife Financial Corporation

Cardinal Capital Management cut its position in Manulife Financial by 580,082 shares, now holding over 4 million shares.

$MFC

Cardinal Capital Management Cuts Position in Canadian Tire Corporation

Cardinal Capital Management has trimmed its stake in Canadian Tire, with current holdings valued at about $90.5 million.

$CDNAF

Cardinal Capital Management Takes New Position in Stantec Inc.

Cardinal Capital Management has established a new stake in Stantec Inc., acquiring over 1.6 million shares valued at about $109.5 million.

$STN

Cardinal Capital Increases Pembina Pipeline Stake Significantly

Cardinal Capital Management boosts its position in Pembina Pipeline Corporation to 7.36 million shares in a recent filing.

$PBA

Cardinal Capital Boosts Stake in Suncor Energy Inc.

Cardinal Capital Management has increased its holdings in Suncor Energy by over 3.18 million shares, reflecting a significant change in its position.

$SU

Banque Pictet Takes New Position in U.S. Bancorp

Banque Pictet & Cie has initiated a new stake in U.S. Bancorp, showing confidence in the financial services company.

$USB

Banque Pictet & Cie Takes New Position in ExxonMobil (XOM)

Banque Pictet & Cie has acquired 41,805 shares of ExxonMobil valued at approximately $6.8 million.

$XOM

Banque Pictet & Cie Increases Stake in Meta Platforms, Inc. (META)

Banque Pictet & Cie has raised its position in Meta Platforms, now holding 380,037 shares valued at $275.6 million.

$META

Banque Pictet Takes New Position in Generate Biomedicines

Banque Pictet & Cie disclosed a new stake in Generate Biomedicines, acquiring 1.77 million shares valued at approximately $26.6 million.

$GENB

Banque Pictet & Cie Increases Stake in AstraZeneca PLC

The firm's position in AstraZeneca now totals 350,235 shares after a significant boost.

$AZN

Banque Pictet Takes New Stake in Amphenol Corporation

The Swiss bank opened a new position in the electronic components maker during the period, adding 351,890 shares.

$APH

Banque Pictet & Cie Trims Position in Boston Scientific Corporation

The institutional investor reduced its stake in the medical device maker by over 690,000 shares during the quarter.

$BSX

Banque Pictet Boosts Stake in Parker-Hannifin Corporation

Banque Pictet & Cie has increased its position in Parker-Hannifin Corporation, raising its stake significantly.

$PH

Banque Pictet & Cie Closes Out Stake in Palo Alto Networks

Recent regulatory filings show Banque Pictet & Cie completely exited its position in cybersecurity provider Palo Alto Networks.

$PANW

Banque Pictet & Cie Cuts Stake in Owens Corning

Banque Pictet & Cie reduced its holdings in Owens Corning by 398,161 shares.

$OC

Banque Pictet Cuts Stake in Moderna, Inc.

Banque Pictet & Cie has decreased its position in Moderna, Inc. by over 548,000 shares.

$MRNA

Banque Pictet & Cie Takes New Position in Vanguard S&P 500 ETF

Banque Pictet & Cie has initiated a new position in Vanguard S&P 500 ETF, acquiring 227,735 shares valued at approximately $159.6 million.

$VOO

Banque Pictet & Cie Cuts Texas Instruments Stake

Banque Pictet & Cie reduced its position in Texas Instruments by over 669,000 shares.

$TXN

ARS Wealth Advisors Group Takes New Position in Gilead Sciences

ARS Wealth Advisors Group has acquired 1,458 shares of Gilead Sciences, valued at $217,280.

$GILD

ARS Wealth Advisors Group Sells Entire Position in Regal Rexnord Corporation

ARS Wealth Advisors Group cut its entire stake in Regal Rexnord Corporation, selling 944 shares in a filing on October 16, 2026.

$RRX

ARS Wealth Advisors Group Sells Out of Dominion Energy (D)

ARS Wealth Advisors Group sold its entire position in Dominion Energy, marking a complete exit from the stock.

$D

Get trade alerts by text